518 related articles for article (PubMed ID: 15990995)
1. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
3. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
4. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
6. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
8. Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes.
Ferrari S; Tagliafico E; Ceccherelli G; Selleri L; Calabretta B; Donelli A; Temperani P; Sarti M; Sacchi S; Emilia G
Leukemia; 1989 Jun; 3(6):423-30. PubMed ID: 2542700
[TBL] [Abstract][Full Text] [Related]
9. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
12. Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination.
Karnik MP; Nair CN; Zingde SM; Gothoskar BP; Zachariah L; Barbhaya S; Advani SH
Indian J Med Res; 1994 Dec; 100():272-6. PubMed ID: 7829166
[TBL] [Abstract][Full Text] [Related]
13. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
14. [Changes in serum RNase activities in chronic phase and acute crisis of chronic myelocytic leukemia].
Maruoka K; Yamanaka M; Misago M; Nakata K; Tsukada J; Nagata K; Sato T; Mori N; Oda S; Chiba S
Rinsho Ketsueki; 1989 Jul; 30(7):988-93. PubMed ID: 2810801
[TBL] [Abstract][Full Text] [Related]
15. Detection of leukemic blasts in peripheral blood specimens by reverse transcriptase polymerase chain reaction assay for myeloperoxidase mRNA.
Zhang W; Austin GE; Farhi DC; Zaki SR
Diagn Mol Pathol; 1993 Dec; 2(4):283-9. PubMed ID: 8118606
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
17. Use of Myeloperoxidase mRNA in Monitoring Patients With Acute Myelogenous Leukemia for Early Detection of Circulating Blasts.
Crisan D; David D
Mol Diagn; 1996 Dec; 1(4):313-319. PubMed ID: 10462578
[TBL] [Abstract][Full Text] [Related]
18. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase gene expression in acute leukemias.
Morishita Y; Yano K
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1459-62. PubMed ID: 2560887
[TBL] [Abstract][Full Text] [Related]
20. The value of the ultrastructural pattern of myeloperoxidase and platelet peroxidase in identification of two blastic cell types during transformation of a chronic myeloproliferative disorder.
Moldoveanu E; Moicean A; Colita A; Halalau F
Haematologia (Budap); 1996; 27(3):135-41. PubMed ID: 14653450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
